Puretech Health Share Discussion Threads

[edwardt] 19/3/2024 08:53

would help if i read the announcement properly!

[edwardt] 19/3/2024 08:47

looks like it will be via divi given mr marker's reaction.

[rimau1] 19/3/2024 08:44

Method of return is unfortunately always divisive. Personally a tender was always likely, it was discussed on this BB as the most likely outcome. Feel better knowing they have already completed an accretive buyback programme at an average stock price of under £2.....you must be in the money Bisiboy which is another reason to be happy. Buybacks have to occur in the open market and completing a $100m buyback on a low volume stock would have taken years.

[bisiboy] 19/3/2024 08:27

i'm not that happy rather they did a buy back in the market to pick up weak holders
they could have picked a fair few up at under 250p

[rimau1] 19/3/2024 08:04

Sold yesterdays acquired trading pot for a very sweet 10percent profit in half a day! Excellent management decision, good balance between return and investment. Long and strong!

[brianblu] 19/3/2024 07:02

PATIENCE 👊

[colinblackbourn] 18/3/2024 14:20

PureTech is Peel Hunts top healthcare pick with a 930p target

[rimau1] 18/3/2024 14:04

Biotech investment requires patience and detailed research.

[tomavery19] 18/3/2024 13:47

Dnt think many care about this deal and fhe mms dnt care either. They didnt even spike this upSeems like this is it for now

[ohisay] 18/3/2024 13:44

Good they did an RNS ..now the wider market will notice Im sure .

Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion

Acquisition centered on KarXT, which was invented at PureTech, as a potential first-in-class treatment for schizophrenia in adults
PureTech to receive approximately $293 million gross proceeds from Karuna equity position in addition to being eligible for further milestones and royalty payments based on KarXT regulatory & commercial successes
PureTech intends to provide an update in the coming days regarding its capital return plan

[edwardt] 18/3/2024 13:41

more than just royalty payments potentially due still is how i read this....

PureTech retains the right to receive milestone payments upon the achievement of certain regulatory approvals. PureTech is also owed certain royalties on net sales and is eligible to receive up to $400 million in milestone payments under its agreement with Royalty Pharma[1].

[beatme1] 18/3/2024 13:40

Moves so slowly not even worth buying

[rimau1] 18/3/2024 13:35

Capital return policy will be updated over the coming days

[colinblackbourn] 18/3/2024 13:23

$294m on its way

[mighunter] 18/3/2024 12:52

Completed - hTTps://x.com/karunatx/status/1769707862777823278?s=46&t=TOGKOShKnAkemOhFT8pfwA

[rimau1] 18/3/2024 12:24

Bought a trading pot at 1.97 for an expected bounce this week, lets see. No advice!!!

[colinblackbourn] 17/3/2024 08:02

There are very significant tax losses if you look towards the end of last years accounts.

[2theduke] 17/3/2024 07:43

Rimou / do you think the c$294m due to prtc on completion of krtx buy out is gross of tax ? If so that tax rate needs to be taken in to account for nav.
Otherwise I agree with your views and values.

[rogers49] 16/3/2024 18:21

I must say it's been an interesting afternoon.

[rimau1] 16/3/2024 17:26

Arix - No. absolutely not. 2023 was the bottom of Biotech as you probably know. Terribly mis-managed. But hey, we go again.

[colinblackbourn] 16/3/2024 17:19

Surely in a bear market shareholders wanted to exit Arix.Timing was wrong for Puretech to acquire but now with the Karuna cash it would be a good deal.RL has plenty of experience and connections you cannot deny that.

[colinblackbourn] 16/3/2024 17:05

If Seaport and Gallop get external funding then cash burn is significantly reduced with only LYT 100 costing money plus general overheads.if LYT 100 looks a no brainer on the readout then maybe a phase three trial and take it all the way to launch.possibility selling ROW rights.potentially a few billion of sales.

[rimau1] 16/3/2024 16:57

We can agree to disagree....

[colinblackbourn] 16/3/2024 16:53

I'm sure Daphne can steer is expertise in the right direction.

[rimau1] 16/3/2024 16:44

Not the biggest fan to be honest, he sold Arix on the cheap to RTW. when execs sell out significantly below NAV its an amber flag for me. I had a decent Arix holding so understand the dynamics over there.